Taken together, these results indicated that mesenchymal-like NSCLC cells tend to be sensitive to statin, whereas epithelial-like NSCLC cells, with membrane expression of E-cadherin, tend to be relatively statin-resistant. Here, CDH1 is linked to non-small cell lung carcinoma.